Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells
- PMID: 15620461
- DOI: 10.1016/j.humimm.2004.10.002
Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells
Abstract
The nonclassic human leukocyte antigen (HLA)-DM molecules have been proved to positively regulate antigen presentation in classic antigen-presenting cells, whereas in B lymphocytes HLA-DO have been identified as negative regulators of the process. The present report examines whether the negative expression of classic class II molecules in trophoblasts implies negative regulation by HLA-DO. It was revealed by immunofluorescence, confocal microscopy, and subcellular fractionation techniques that human trophoblasts, although not expressing any surface HLA-DR antigens, constitutively express intracellular HLA-DR, HLA-DO, and CD74, but not HLA-DM. Administration of interferon-gamma to the cell culture increased HLA-DR and CD74, induced HLA-DM, but did not alter the expression of HLA-DO and induced HLA-DR release from the cells. These results were confirmed by reverse transcriptase-polymerase chain reaction analysis except that HLA-DM mRNA was detected in control cells, indicating a posttranscriptional regulation. Under the same experimental conditions, human monocytes/macrophages were not expressing intracellular HLA-DO while exhibiting significant levels of HLA-DR, HLA-DM, and CD74. The results presented here reveal for the first time expression of HLA-DO in trophoblasts, which can be of great importance in maintaining the class II-negative state in these cells and consequently protecting the fetus from maternal immune attack.
Similar articles
-
Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.J Immunol. 1998 Apr 1;160(7):3207-16. J Immunol. 1998. PMID: 9531276
-
Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.Br J Haematol. 2009 May;145(3):334-43. doi: 10.1111/j.1365-2141.2009.07625.x. Epub 2009 Feb 24. Br J Haematol. 2009. PMID: 19245431
-
Discordant expression of HLA class II-associated co-chaperones and HLA-DRB alleles in cultured fibroblast-like synoviocytes.Hum Immunol. 2004 Dec;65(12):1516-29. doi: 10.1016/j.humimm.2004.09.005. Hum Immunol. 2004. PMID: 15603880
-
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?Oncogene. 2003 Sep 29;22(42):6564-9. doi: 10.1038/sj.onc.1206960. Oncogene. 2003. PMID: 14528281 Review.
-
DM and DO shape the repertoire of peptide-MHC-class-II complexes.Curr Opin Immunol. 2005 Feb;17(1):65-70. doi: 10.1016/j.coi.2004.11.003. Curr Opin Immunol. 2005. PMID: 15653313 Review.
Cited by
-
Oxygen regulates ILC3 antigen presentation potential and pregnancy-related hormone actions.Reprod Biol Endocrinol. 2022 Jul 29;20(1):109. doi: 10.1186/s12958-022-00979-2. Reprod Biol Endocrinol. 2022. PMID: 35906658 Free PMC article.
-
New Paradigm in the Role of Regulatory T Cells During Pregnancy.Front Immunol. 2019 Mar 26;10:573. doi: 10.3389/fimmu.2019.00573. eCollection 2019. Front Immunol. 2019. PMID: 30972068 Free PMC article. Review.
-
The remission of rheumatoid arthritis during pregnancy.Semin Immunopathol. 2007 Jun;29(2):185-91. doi: 10.1007/s00281-007-0072-5. Semin Immunopathol. 2007. PMID: 17621703 Review.
-
Class II MHC antigen processing in immune tolerance and inflammation.Immunogenetics. 2019 Mar;71(3):171-187. doi: 10.1007/s00251-018-1095-x. Epub 2018 Nov 12. Immunogenetics. 2019. PMID: 30421030 Free PMC article. Review.
-
The Th1/Th2 paradigm: still important in pregnancy?Semin Immunopathol. 2007 Jun;29(2):95-113. doi: 10.1007/s00281-007-0069-0. Semin Immunopathol. 2007. PMID: 17626305 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials